Alanous Therapeutics has a total of 192 patents globally, out of which 95 have been granted. Of these 192 patents, more than 05% patents are active. United States of America is where Alanous Therapeutics has filed the maximum number of patents, followed by Japan and Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Alanous Therapeutics.
Alanous Therapeutics was founded in the year 2005. The Company operates as a clinical stage cellular immuno-oncology company. The Company focuses on the treatment of solid tumors through adoptive TCR-T cell therapy.
Do read about some of the most popular patents of Alanous Therapeutics which have been covered by us in this article and also you can find Alanous Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Alanous Therapeutics patent portfolio.
How many patents does the founder and the CEO of Alanous Therapeutics have?
The founder Jonathan Lewis has 1 patent and CEO Kevin Boyle has 0 patents.
How many patents does Alanous Therapeutics have?
Alanous Therapeutics has a total of 192 patents globally. These patents belong to 22 unique patent families. Out of 192 patents, 11 patents are active.
How Many Patents did Alanous Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
Year of Patents Filing or Grant | Alanous Therapeutics Applications Filed | Alanous Therapeutics Patents Granted |
2020 | 1 | – |
2019 | – | 1 |
2017 | – | 1 |
2016 | 1 | 12 |
2015 | 2 | 18 |
2014 | 5 | 8 |
2013 | 10 | 6 |
2012 | 2 | 7 |
2011 | 8 | 4 |
2010 | 9 | 8 |
How many Alanous Therapeutics patents are Alive/Dead?
How Many Patents did Alanous Therapeutics File in Different Countries?
Countries in which Alanous Therapeutics Filed Patents
Country | Patents |
United States of America | 27 |
Japan | 9 |
Canada | 9 |
Europe | 9 |
Australia | 9 |
China | 8 |
New Zealand | 8 |
Taiwan | 7 |
Austria | 7 |
Singapore | 7 |
Israel | 7 |
Hong Kong (S.A.R.) | 6 |
Korea (South) | 5 |
Brazil | 5 |
Germany | 5 |
Denmark | 5 |
India | 5 |
Norway | 5 |
Spain | 4 |
South Africa | 4 |
Slovakia | 3 |
Russian Federation | 3 |
Portugal | 3 |
Mexico | 3 |
Poland | 3 |
Estonia | 2 |
Indonesia | 2 |
Hungary | 2 |
Slovenia | 2 |
Chile | 1 |
Cyprus | 1 |
Serbia | 1 |
Croatia | 1 |
Gulf Cooperation Council | 1 |
Where are Research Centres of Alanous Therapeutics Patents Located?
10 Best Alanous Therapeutics Patents
US6693119B2 is the most popular patent in the Alanous Therapeutics portfolio. It has received 36 citations so far from companies like Baxter International, Ironwood Pharmaceuticals and Bed Therapeutics.
Below is the list of 10 most cited patents of Alanous Therapeutics:
Publication Number | Citation Count |
US6693119B2 | 36 |
US20060110462A1 | 24 |
US7452910B2 | 8 |
US20060280787A1 | 7 |
US20060040991A1 | 7 |
US9346836B2 | 5 |
US7579365B2 | 5 |
US20030023093A1 | 5 |
US6919344B2 | 4 |
US20080027110A1 | 3 |
What are Alanous Therapeutics key innovation segments?
What Technologies are Covered by Alanous Therapeutics?
The chart below distributes patents filed by Alanous Therapeutics